Skip to main navigation
Skip to search
Skip to main content
Monash University Home
Help & FAQ
Home
Profiles
Research units
Equipment
Projects
Outputs
Prizes
Activities
Press/Media
Search by expertise, name or affiliation
A Phase 2/3 Multicenter, Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate the Efficacy, Safety and Tolerability of BHV 7000 in Subjects with Refractory Focal Onset Epilepsy
O'Brien, Terence
(Primary Chief Investigator (PCI))
School of Translational Medicine
Project
:
Research
Overview
Project Details
Status
Active
Effective start/end date
10/12/24
→
10/12/26
View all
View less
Keywords
clinical trial
epilepsy
refractory disease